ONMEL

LOE ApproachingSM

itraconazole

NDAORALTABLET
Approved
Apr 2010
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
20

Clinical Trials (5)

NCT07435194Phase 1Not Yet Recruiting

A Clinical Trial in Healthy Participants to Learn How Itraconazole Affects MK-2828 Levels and How MK-2828 Affects Midazolam Levels (MK-2828-007)

Started Mar 2026
28 enrolled
Healthy
NCT07308652Phase 1Active Not Recruiting

A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the Blood

Started Feb 2026
14 enrolled
Healthy
NCT07395024Phase 1Recruiting

A Study to Learn How Fluconazole, Carbamazepine and Itraconazole Affect How the Body Processes ASP3082 in Healthy Adults

Started Feb 2026
54 enrolled
Healthy Volunteer
NCT07402915Phase 1Recruiting

Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Started Jan 2026
24 enrolled
Fallopian Tube CancerOvarian CancerPrimary Peritoneal
NCT07335419Phase 1Recruiting

A Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)

Started Jan 2026
12 enrolled
Healthy Adult Participants

Loss of Exclusivity

LOE Date
Oct 3, 2028
31 months away
Patent Expiry
Oct 3, 2028

Patent Records (1)

Patent #ExpiryTypeUse Code
8486456
Oct 3, 2028
Product
U-1054